🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

Todos Aviação Tecnologia Aviação Executiva Negócios Desenvolvimento Web Empreendedorismo Comunidade Empresas Dicas ESG Caso de Sucesso Esportes Notícias Inteligência Artificial Eventos Investimentos IoT Marketing Meio Ambiente Sistemas ERP
188 notícias encontradas para "significant"
Many treatments help chronic back pain, but only in the short term
A large-scale analysis by an international research team, led by Bochum University of Applied Sciences, shows that nonsurgical treatments such as massage, exercise therapy or acupuncture for chronic back pain can alleviate symptoms—but usually only for a few weeks. Clinically sig
Admin Recifes 15/07/2026 1
A new framework to advocate for improving the quality of life of people with rheumatic and
Rheumatic and musculoskeletal diseases (RMDs) contribute significantly to the disability and health care burden in Europe, but until now there has been no harmonized, specific data set to help systematically compare differences in rheumatology workforces, health resources and acc
Admin Recifes 15/07/2026 1
GLP-1 drugs outperform SGLT-2 drugs for patients with Afib and type 2 diabetes
Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney disease and heart failure. These risks are significantly exacerbated if a type 2 diabetes diagnosis is added to the mix, says Md Mohaimenul Islam, Ph.D., resear
Admin Recifes 15/07/2026 1
Should lowest-risk prostate 'cancer' still be called cancer? How changing the name could s
Should lowest-risk prostate 'cancer' still be called cancer? How changing the name could s
A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could dramatically reduce overtreatment and encourage more men to get screened, potentially leadi
Admin Recifes 15/07/2026 1
Hearing loss in diabetes patients a 'hidden epidemic'
Researchers are calling for hearing tests to become a standard part of diabetes care and for hearing loss to be recognized as a significant complication of the condition. Dr. Mehwish Nisar from UQ's School of Public Health said most people were unaware there was even a connection
Admin Recifes 15/07/2026 1
Most breast imaging facilities in both high- and low-deprivation areas offer digital breas
Most breast imaging facilities in both high- and low-deprivation areas offer digital breas
New research has found that digital breast tomosynthesis (DBT) availability at breast imaging facilities is similar across low- and high-deprivation areas, but facilities in low-deprivation areas are significantly more likely to offer weekend appointments, which may affect access
Admin Recifes 15/07/2026 1
Patients in Hawai'i spent $230M+ on out-of-state cancer care in 2021–2023, study finds
A new study led by researchers at the University of Hawaiʻi Cancer Center found that at least $230 million was spent on cancer care delivered outside Hawaiʻi between 2021 and 2023, highlighting the significant financial impact of geographic isolation on patients and the health ca
Admin Recifes 15/07/2026 1
Repurposed cancer drug rapidly eased rare autoimmune neuropathy in two patients
An interdisciplinary team at Jena University Hospital achieved a surprisingly rapid and significant improvement in two patients with an autoimmune peripheral nervous system disorder. The team administered teclistamab, a drug originally developed for multiple myeloma, and reported
Admin Recifes 15/07/2026 1
Foto: Lucas Oliveira / Pexels
New AI system provides treatment recommendations for complex blood cancers
Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute and Heidelberg University Hospital (UKHD) have developed "HemaGuide," an AI assistant that supports physicians in making difficult treatment decisions. In extensive testing, the system has
Admin Recifes 15/07/2026 1
Pembrolizumab-belzutifan tied to improved disease-free survival in renal cell carcinoma
For patients with clear-cell renal cell carcinoma, pembrolizumab-belzutifan yields significantly higher disease-free survival, according to a study published in the July 2 issue of the New England Journal of Medicine.
Admin Recifes 15/07/2026 0
Radioligand therapy significantly prolongs progression-free survival in metastatic GEP-NET
Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) compared with targeted therapy
Admin Recifes 15/07/2026 1
New approach could expand CAR T therapy from blood cancers to solid tumors
New approach could expand CAR T therapy from blood cancers to solid tumors
Researchers at the University of Pittsburgh, UPMC Hillman Cancer Center and the National Cancer Institute report that combining CAR T cell immunotherapy with a targeted radiopharmaceutical significantly improved tumor regression in preclinical models of neuroblastoma, a rare and
Admin Recifes 15/07/2026 1
← Anterior 1 … 3 4 5 … 16 Próximo →